New J.P. Morgan Report Details Savings and Usage Habits of More Than 500,000 Health Savings Account Holders

NEW YORK--(BUSINESS WIRE)-- J.P. Morgan Treasury Services, administrator of the J.P. Morgan Health Savings Account (HSA) program, today released insight into the saving, spending and investing habits of its more than 500,000 HSA accountholders. J.P. Morgan’s HSA Program Snapshot provides the healthcare industry and employers with a better understanding of product usage patterns and trends, and demonstrates first-hand how HSAs have become an integral part of helping Americans save and pay for medical expenses.

“As a pioneer and leading provider of consumer-directed healthcare solutions, J.P. Morgan is uniquely positioned to deliver insight into HSA accountholder activity and behavior,” said David Josephs, Managing Director, J.P. Morgan. “Through the HSA Snapshot, we share information on account balances, contribution and distribution activity, as well as trends in investment behavior. We also expect employers who are offering HSAs for the first time, or those who already have programs in place, to use the Snapshot as they review health plan options for the upcoming enrollment season or as a benchmark for comparison.”

The report is based on 2009 accountholder activity. Among the highlights:

  • 45% of accounts have balances over $1,000 as of 12/31/09 compared to 35% at the end of 2008
  • Accounts with higher cash balances are becoming more common. The percentage of accounts with balances under $500 decreased from 50% at the end of 2008 to 42% in 2009. The percentage of accounts with balances over $2,000 increased from 20% at the end of 2008 to 31% in 2009
  • 68% of accountholders contributed more than they spent during each month in 2009
  • The average account contribution in 2009 was $1,816
  • Most transactions (70%) are sign for purchase transactions done via a card
  • The average spend or distribution per HSA in 2009 was $1,305, or $109 per month
  • While purchases at drugstores resulted in the highest volume of transactions per account, hospitals and dental expenses had the highest average dollar amount per transaction ($212 and $194 respectively)
  • Most investment dollars were held in equity mutual funds (52%)

A full copy of J.P. Morgan’s HSA Program Snapshot is available at www.jpmorgan.com/hsa.

J.P. Morgan currently manages HSA programs in conjunction with many of the largest health insurance companies in the United States as well as Fortune 500 companies and small businesses across the nation. As of April 2010, J.P. Morgan is managing more than 530,000 HSAs with over $800 million in assets.

About J.P. Morgan Healthcare Solutions

J.P. Morgan Healthcare Solutions provides a comprehensive suite of products, services and financial settlement tools for consumers, insurers, physicians, hospitals and other healthcare providers through two core businesses - Consumer-Directed Healthcare and Business-to-Business Solutions. J.P. Morgan Healthcare Solutions is part of the firm's Treasury Services business. With more than 100,000 clients and services provided in more than 60 countries and 40 states, J.P. Morgan Treasury Services is one of the world's largest providers of treasury management services and a division of JPMorgan Chase Bank, N.A., member FDIC. More information can be found at www.jpmorgan.com/healthcare.

About JPMorgan Chase & Co.

JPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $2.1 trillion and operations in more than 60 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management and private equity. A component of the Dow Jones Industrial Average, JPMorgan Chase & Co. serves millions of consumers in the United States and many of the world's most prominent corporate, institutional and government clients under its J.P. Morgan and Chase brands. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com



CONTACT:

Media:
JPMorgan Chase & Co.
John Murray, 571-934-2808
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Other Health  Professional Services  Banking  Consulting  Finance  Human Resources

MEDIA:

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.